These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17063397)

  • 21. The acidic microclimate in poly(lactide-co-glycolide) microspheres stabilizes camptothecins.
    Shenderova A; Burke TG; Schwendeman SP
    Pharm Res; 1999 Feb; 16(2):241-8. PubMed ID: 10100309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.
    Joguparthi V; Xiang TX; Anderson BD
    J Pharm Sci; 2008 Jan; 97(1):400-20. PubMed ID: 17879989
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preservation of the active lactone form of irinotecan using drug eluting beads for the treatment of colorectal cancer metastases.
    Tang Y; Czuczman PR; Chung ST; Lewis AL
    J Control Release; 2008 Apr; 127(1):70-8. PubMed ID: 18237814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation.
    Li C; Cui J; Wang C; Li Y; Zhang L; Xiu X; Li Y; Wei N; Zhang L; Wang P
    J Pharm Pharmacol; 2011 Jun; 63(6):765-73. PubMed ID: 21585373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple and versatile high-performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of camptothecin anticancer drugs.
    Warner DL; Burke TG
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):161-71. PubMed ID: 9140770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous determination of the lactone and carboxylate forms of 7-ethyl-10-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in rat plasma by high performance liquid chromatography.
    Kaneda N; Hosokawa Y; Yokokura T
    Biol Pharm Bull; 1997 Jul; 20(7):815-9. PubMed ID: 9255427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions.
    Lundberg BB
    Anticancer Drug Des; 1998 Jul; 13(5):453-61. PubMed ID: 9702210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
    Chiu GN; Abraham SA; Ickenstein LM; Ng R; Karlsson G; Edwards K; Wasan EK; Bally MB
    J Control Release; 2005 May; 104(2):271-88. PubMed ID: 15907579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of liposomalization on the antitumor activity, side-effects and tissue distribution of CPT-11.
    Sadzuka Y; Hirotsu S; Hirota S
    Cancer Lett; 1998 May; 127(1-2):99-106. PubMed ID: 9619864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liposomal irinotecan: formulation development and therapeutic assessment in murine xenograft models of colorectal cancer.
    Messerer CL; Ramsay EC; Waterhouse D; Ng R; Simms EM; Harasym N; Tardi P; Mayer LD; Bally MB
    Clin Cancer Res; 2004 Oct; 10(19):6638-49. PubMed ID: 15475454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hexosomes formed from glycerate surfactants--formulation as a colloidal carrier for irinotecan.
    Boyd BJ; Whittaker DV; Khoo SM; Davey G
    Int J Pharm; 2006 Aug; 318(1-2):154-62. PubMed ID: 16621358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid membrane with low proton permeability.
    Biloti DN; Santana MH; Pessine FB
    Biochim Biophys Acta; 2003 Apr; 1611(1-2):1-4. PubMed ID: 12659939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions.
    Modi S; Xiang TX; Anderson BD
    J Control Release; 2012 Sep; 162(2):330-9. PubMed ID: 22800581
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of irinotecan hydrochloride in aqueous solutions.
    Li WY; Koda RT
    Am J Health Syst Pharm; 2002 Mar; 59(6):539-44. PubMed ID: 11908247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of a novel liposome-based formulation of SN-38.
    Zhang JA; Xuan T; Parmar M; Ma L; Ugwu S; Ali S; Ahmad I
    Int J Pharm; 2004 Feb; 270(1-2):93-107. PubMed ID: 14726126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67.
    Joguparthi V; Feng S; Anderson BD
    Int J Pharm; 2008 Mar; 352(1-2):17-28. PubMed ID: 18065174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors.
    Hattori Y; Shi L; Ding W; Koga K; Kawano K; Hakoshima M; Maitani Y
    J Control Release; 2009 May; 136(1):30-7. PubMed ID: 19331859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological correlation between total drug concentration and lactones of CPT-11 and SN-38 in patients treated with CPT-11.
    Sasaki Y; Yoshida Y; Sudoh K; Hakusui H; Fujii H; Ohtsu T; Wakita H; Igarashi T; Itoh K
    Jpn J Cancer Res; 1995 Jan; 86(1):111-6. PubMed ID: 7737902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes.
    Abraham SA; Edwards K; Karlsson G; Hudon N; Mayer LD; Bally MB
    J Control Release; 2004 May; 96(3):449-61. PubMed ID: 15120901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dimeric camptothecin derived phospholipid assembled liposomes with high drug loading for cancer therapy.
    Fang S; Hou Y; Ling L; Wang D; Ismail M; Du Y; Zhang Y; Yao C; Li X
    Colloids Surf B Biointerfaces; 2018 Jun; 166():235-244. PubMed ID: 29604567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.